Asia-Pacific Autoimmune Disease Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The market is segmented By Disease Type (Systemic Autoimmune Disease and Localized Autoimmune Disease), Diagnosis, and Geography

Market Snapshot

CAGR
Study Period: 2018 - 2026
Base Year: 2020
CAGR: >5.5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The treatment of autoimmune diseases requires diagnosis of the disease at the onset of disease or later. This involves clinical laboratories checking for symptoms and providing the information to physician for better treatment of the disease. All the diagnostic laboratories do not have proper equipment for carrying out immunoassays. In that case, patient will face trouble in getting the tests done and then handing over the result to the physician. To overcome these problems, recently physicians and clinical laboratories started collaborating. Since, a physician knows where proper immunoassays and immunodiagnostics can be carried out, physician collaborates with that laboratory and suggests patient to get their tests done from there and the results will directly be sent to the physician. Furthermore, with increasing usage of Electronic Medical Records (EMR), labs have access to real-time test data and metrics extracted from the Laboratory Information System (LIS) and physicians too have access to these records, which increases efficiency in diagnosis, thus boosting autoimmune diagnostics market.

Scope of the report

Autoimmunity involves the loss of normal immune homeostasis, as the organism produces an abnormal response to its own tissue. Autoimmune diseases generally involve the presence of self-reactive T cells, autoantibodies, and inflammation. 

By Disease Type
Systemic Autoimmune Disease
Rheumatoid Arthritis
Psoriasis
Systemic Lupus Erythematosus (SLE)
Multiple Sclerosis
Other Systemic Autoimmune Diseases
Localized Autoimmune Disease
Inflammatory Bowel Disease
Type 1 Diabetes
Thyroid
Other Localized Autoimmune Diseases
By Diagnosis
Regular Laboratory Tests
Inflammatory Markers
Immunologic Assays
Antibody Tests
Other Tests
Geography
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific

Report scope can be customized per your requirements. Click here.

Key Market Trends

Immunologic Assays Segment is Expected to Show Better Growth During the Forecast Years

Based on Diagnosis, the market is segmented into Regular Laboratory Tests, Inflammatory Markers, Immunologic Assays, Antibody Tests and Other Tests. The factors responsible for the growth of the market include cost-effectiveness, growth in the biotechnology and pharmaceutical sectors, and high sensitivity and specificity of immunoassays. When compared to conventional tests, immunologic assays have been proven to provide highly accurate results, even with very small samples. 

Immunologic reactions are highly specific, as they can take place only in the presence of proper immunologic agents. This high specificity indicates high accuracy in results, enabling high sensitivity in the detection of diseases. It helps in easy detection and eliminates the need for secondary verification, which ultimately saves costs. Hence, owing to these factors, the segment is expected to show better growth in the forecast period.

Asia-Pacific Autoimmune Disease Diagnostics Market 1

To understand key trends, Download Sample Report

Competitive Landscape

The market comprises of major market players, and these players are focusing on R&D activities and significant growth strategies. The major players into the Asia-Pacific autoimmune disease diagnostics market are Abbott Laboratories, BioMerieux, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd, PerkinElmer Inc., Siemens AG, Trinity Biotech and Thermo Fisher Scientific.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growing Public Awareness about Autoimmune Diseases

      2. 4.2.2 Partnerships with Physicians and Clinical Laboratories

      3. 4.2.3 Technological Advancements

    3. 4.3 Market Restraints

      1. 4.3.1 Slow Turnaround Time for Autoimmune Disease Diagnostic Test Results

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Disease Type

      1. 5.1.1 Systemic Autoimmune Disease

        1. 5.1.1.1 Rheumatoid Arthritis

        2. 5.1.1.2 Psoriasis

        3. 5.1.1.3 Systemic Lupus Erythematosus (SLE)

        4. 5.1.1.4 Multiple Sclerosis

        5. 5.1.1.5 Other Systemic Autoimmune Diseases

      2. 5.1.2 Localized Autoimmune Disease

        1. 5.1.2.1 Inflammatory Bowel Disease

        2. 5.1.2.2 Type 1 Diabetes

        3. 5.1.2.3 Thyroid

        4. 5.1.2.4 Other Localized Autoimmune Diseases

    2. 5.2 By Diagnosis

      1. 5.2.1 Regular Laboratory Tests

      2. 5.2.2 Inflammatory Markers

      3. 5.2.3 Immunologic Assays

      4. 5.2.4 Antibody Tests

      5. 5.2.5 Other Tests

    3. 5.3 Geography

      1. 5.3.1 Asia-Pacific

        1. 5.3.1.1 China

        2. 5.3.1.2 Japan

        3. 5.3.1.3 India

        4. 5.3.1.4 Australia

        5. 5.3.1.5 South Korea

        6. 5.3.1.6 Rest of Asia-Pacific

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 BioMerieux

      3. 6.1.3 Bio-Rad Laboratories, Inc.

      4. 6.1.4 F. Hoffmann-La Roche Ltd

      5. 6.1.5 PerkinElmer, Inc.

      6. 6.1.6 Siemens AG

      7. 6.1.7 Trinity Biotech

      8. 6.1.8 Thermo Fisher Scientific

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Asia-Pacific Autoimmune Disease Diagnostics Market market is studied from 2018 - 2026.

The Asia-Pacific Autoimmune Disease Diagnostics Market is growing at a CAGR of >5.5% over the next 5 years.

Abbott Laboratories, BioMerieux, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific are the major companies operating in Asia-Pacific Autoimmune Disease Diagnostics Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!